Handbook of Hypertension
(Sprache: Englisch)
When treating hypertension, physicians now have a huge range of drugs from which to choose in formulating a management strategy. This accessible guide helps the busy clinician access specific information on available drugs as components of an integrated care plan.
Leider schon ausverkauft
versandkostenfrei
Buch (Kartoniert)
78.76 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Handbook of Hypertension “
When treating hypertension, physicians now have a huge range of drugs from which to choose in formulating a management strategy. This accessible guide helps the busy clinician access specific information on available drugs as components of an integrated care plan.
Klappentext zu „Handbook of Hypertension “
When treating hypertension, physicians now have a huge range of drugs from which to choose in formulating a management strategy. This accessible guide helps the busy clinician access specific information on available drugs as components of an integrated care plan.The Handbook of Hypertension is a comprehensive review of the evidence base for hypertension and associated disease, providing tables, figures, charts, and summaries of principal findings from clinical studies on hypertension - putting vital information within reach of the busy practitioner.
Containing the most recent guidelines for global cardiovascular risk analysis and evidence-based reviews on important new advances and recent trials, consulting the Handbook of Hypertension will save precious time and improve patient care.
When treating hypertension, physicians now have a huge range of drugs from which to choose in formulating a management strategy. This accessible guide helps the busy clinician access specific information on available drugs as components of an integrated care plan. Tables, figures, charts, and summaries of principal findings from clinical studies on hypertension put vital information within reach. Consulting the Handbook of Hypertension will save precious time and improve patient care.
Inhaltsverzeichnis zu „Handbook of Hypertension “
Provisional Table of ContentsAbbreviations
General Introduction
Introduction
Hypertension Syndrome
Vascular Biology
Functional Endothelium
Endothelial Dysfunction
New Treatment Approach
Hypothesis: Essential Hypertension and End-Organ Damage
Hypertension Classification and Guidelines Wordwide
Hypertension in the US
JNC-7
NHANES III and IV
CHS
ESH-ESC
ISHIB
AHA
BHS/NICE(RCP)
JBS 2
Global Cardiovascular Risk Calculation
Secondary Hypertension
Measurement of Blood Pressure
Indirect measurement of blood pressure
Korotkoff Sounds
Common Mistakes in Blood Pressure Measurement
Hypertension-Atherosclerotic Syndrome
Normotensive Hypertension
Pre-hypertension
Nonpharmacologic Treatment of Hypertension
Nutrition
Nutraceuticals, Vitamins, Minerals and Antioxidants
DASH I and II Trials
Specific Recommendations
Obesity
Exercise
Approaches to Selection of Antihypertensive Therapy
Stepped Care
Demographics
Subsets of Hypertension
Renin Profiling: The Laragh Method
Hemodynamics in Hypertension
Hemodynamics: Logical and Preferred Method to Reduce Blood Pressure
Hemodynamic Effects of Antihypertensive Drugs
Hypertension-Related End-Organ Damage
Life Expectancy and Blood Pressure
Systolic, Diastolic and Pulse Pressure Concepts
Isolated Systolic Hypertension
Clinical Hypertension Trials and Antihypertensive
Drug Therapy
Completed Trials and Trials in Progress
Diuretic and Beta-Blocker Trials
Summary of Clinical Trials with Diuretics
Summary of Clinical Trials with Beta-Blockers
Meta-Analysis of Various Clinical Trials
Comparisons of ACE-Inhibitor therapy with Placebo
Comparisons of Calcium-antagonist therapy with Placebo
Comparisons of More Intensive Blood Pressure Lowering Strategies with Less
Intensive Strategies
Comparisons of Ace-Inhibitor based Therapy with Diuretic-based or Beta-Blocker
... mehr
Therapy
Comparisons of Calcium-antagonist-based Therapy with Diuretic or Beta-BlockerTherapy
Comparisons of Ace-Inhibitor Therapy with Calcium-antagonist Therapy
Summary of Clinical Trials in Hypertension and Clinical Outcomes
Health Outcomes Meta-Analysis
Comparing the CCBs to other Antihypertensive Therapy
ALLHAT Trial
ALLHAT: Conclusions
ASCOT Trial
Summary of Published Trials Involving CCBs
Angiotensin Converting Enzyme Inhibitors (ACEI) Trials
Summary of ACEI Trials
Angiotensin Receptor Blockers (ARBs) Trials
ARBs Trials Summary
Coronary Heart Disease Risk Factor and Effects of Anti-hypertensive Drug Therapy
Coronary Heart Disease: Risk Factors
Coronary Heart Disease Risk Factors: More potential risk factors
Influence of Diuretic and Beta-Blocker Therapy on CHD Risk Factors
Antihypertensive Drugs and Serum Lipids
Summary of Serum Lipids and Antihypertensive Therapy with Diuretics and
Beta Blockers
Effects of Antihypertensive Drugs on Coronary Heart Disease Risk Factors
Antihypertensive Drugs and Coronary Heart Disease Risk Factors: Summary
Calcium Channel Blockers and Atherosclerosis (CHD Reduction Trials)
Hypertension and Renal Disease
Classification of Chronic Kidney Disease
Hypertension and Renal Damage
Hypertension-Related Renal Damage:
Postulated Mechanisms
Is Thiazide Diuretic-Based Antihypertensive Therapy Associated with Increased
Risk of Renal Injury
Major Clinical Trials Showing Renoprotection
Effects of Antihypertensive Drugs on Renal Function
Hypertension and Diabetes Mellitus
Hypertensive Diabetics: Mortality, Coronary Heart Disease and Antihypertensive
Therapy
BP Level Effects on Type II-DM Nephropathy
RENAAL TRIAL
Diabetes Mellitus and Hypertension Summary
Selection of Therapy Based on Subsets of Hypertension
Demographics and Antihypertensive Drugs
Resistant Hypertension
Isolated Systolic Hypertension in the Elderly
Hypertensive Urgencies and Emergencies
Treatment; General Principles
Treatment; Choice of Drug
Treatment of Specific Hypertensive Disorders
Hypertension in Pregnancy
General Review of Antihypertensive Drug Therapy
Quality of Life and Antihypertensive Therapy (Selected Trials)
Antihypertensive Drug Compliance
Total Cost of Antihypertensive Therapy
Characteristics of the Ideal Antihypertensive Drug
Combination Antihypertensive Therapy: Selected Drugs
Combination Antihypertensive Therapy: Selected Drugs: Summary
Antihypertensive Therapy: Efficacy of Monotherapy
Selected Drug Interactions with Antihypertensive Therapy
Maximum Recommended Doses of Antihypertensive Drugs with Best Treatment Characteristics
Specific Review of all Antihypertensive Drug Classes
Diuretics
Diuretics Highlights
Central Alpha-Agonists
Central Alpha-Agonists: Similarities
Central Alpha-Agonists: Highlights
Comparison of Commonly Used Oral Central Alpha-Agonists
Postganglionic Neuron Inhibitors
Postganglionic Neuron Inhibitors Highlights
Beta-Blockers--General
Side Effects and Contraindications of Beta-Blockers
Drug Interactions with Beta-Blockers
Beta-Blockers Highlights
Direct Vasodilators
Direct Vasodilators Highlights
Alpha1-Blockers
Alpha1-Blockers: Highlights
Angiotensin-Converting Enzyme (ACE) Inhibitors
Renin-Angiotensin System (RAAS)
ACE Inhibitors: Highlights
Non Hypertensive Treatment Effects of ACEIs
Calcium Channel Blockers
Calcium Channel Blockers: Highlights
Treatment: Non Hypertensive Effects of CCBs
Angiotensin II Receptor Blockers (ARBs)
Ang-II Receptor Blockers (ARBs): Highlights
Non Hypertensive Treatment effects of ARB's
Renin Inhibitors
Serum Aldosterone Receptor Antagonists (SARA's)
Combination of Anti-hypertensive Drug with Statin ( Amlodipine with Atorvastatin)
Arterial Compliance: Structure/Function: Treatment
Selected Combination Antihypertensive Drugs
Hypertension Drug Selection: Summary
New Antihypertensive Drug Classes
Subset Selection of Antihypertensive Therapy
Conclusions 383
References 385
Index 400
Comparisons of Calcium-antagonist-based Therapy with Diuretic or Beta-BlockerTherapy
Comparisons of Ace-Inhibitor Therapy with Calcium-antagonist Therapy
Summary of Clinical Trials in Hypertension and Clinical Outcomes
Health Outcomes Meta-Analysis
Comparing the CCBs to other Antihypertensive Therapy
ALLHAT Trial
ALLHAT: Conclusions
ASCOT Trial
Summary of Published Trials Involving CCBs
Angiotensin Converting Enzyme Inhibitors (ACEI) Trials
Summary of ACEI Trials
Angiotensin Receptor Blockers (ARBs) Trials
ARBs Trials Summary
Coronary Heart Disease Risk Factor and Effects of Anti-hypertensive Drug Therapy
Coronary Heart Disease: Risk Factors
Coronary Heart Disease Risk Factors: More potential risk factors
Influence of Diuretic and Beta-Blocker Therapy on CHD Risk Factors
Antihypertensive Drugs and Serum Lipids
Summary of Serum Lipids and Antihypertensive Therapy with Diuretics and
Beta Blockers
Effects of Antihypertensive Drugs on Coronary Heart Disease Risk Factors
Antihypertensive Drugs and Coronary Heart Disease Risk Factors: Summary
Calcium Channel Blockers and Atherosclerosis (CHD Reduction Trials)
Hypertension and Renal Disease
Classification of Chronic Kidney Disease
Hypertension and Renal Damage
Hypertension-Related Renal Damage:
Postulated Mechanisms
Is Thiazide Diuretic-Based Antihypertensive Therapy Associated with Increased
Risk of Renal Injury
Major Clinical Trials Showing Renoprotection
Effects of Antihypertensive Drugs on Renal Function
Hypertension and Diabetes Mellitus
Hypertensive Diabetics: Mortality, Coronary Heart Disease and Antihypertensive
Therapy
BP Level Effects on Type II-DM Nephropathy
RENAAL TRIAL
Diabetes Mellitus and Hypertension Summary
Selection of Therapy Based on Subsets of Hypertension
Demographics and Antihypertensive Drugs
Resistant Hypertension
Isolated Systolic Hypertension in the Elderly
Hypertensive Urgencies and Emergencies
Treatment; General Principles
Treatment; Choice of Drug
Treatment of Specific Hypertensive Disorders
Hypertension in Pregnancy
General Review of Antihypertensive Drug Therapy
Quality of Life and Antihypertensive Therapy (Selected Trials)
Antihypertensive Drug Compliance
Total Cost of Antihypertensive Therapy
Characteristics of the Ideal Antihypertensive Drug
Combination Antihypertensive Therapy: Selected Drugs
Combination Antihypertensive Therapy: Selected Drugs: Summary
Antihypertensive Therapy: Efficacy of Monotherapy
Selected Drug Interactions with Antihypertensive Therapy
Maximum Recommended Doses of Antihypertensive Drugs with Best Treatment Characteristics
Specific Review of all Antihypertensive Drug Classes
Diuretics
Diuretics Highlights
Central Alpha-Agonists
Central Alpha-Agonists: Similarities
Central Alpha-Agonists: Highlights
Comparison of Commonly Used Oral Central Alpha-Agonists
Postganglionic Neuron Inhibitors
Postganglionic Neuron Inhibitors Highlights
Beta-Blockers--General
Side Effects and Contraindications of Beta-Blockers
Drug Interactions with Beta-Blockers
Beta-Blockers Highlights
Direct Vasodilators
Direct Vasodilators Highlights
Alpha1-Blockers
Alpha1-Blockers: Highlights
Angiotensin-Converting Enzyme (ACE) Inhibitors
Renin-Angiotensin System (RAAS)
ACE Inhibitors: Highlights
Non Hypertensive Treatment Effects of ACEIs
Calcium Channel Blockers
Calcium Channel Blockers: Highlights
Treatment: Non Hypertensive Effects of CCBs
Angiotensin II Receptor Blockers (ARBs)
Ang-II Receptor Blockers (ARBs): Highlights
Non Hypertensive Treatment effects of ARB's
Renin Inhibitors
Serum Aldosterone Receptor Antagonists (SARA's)
Combination of Anti-hypertensive Drug with Statin ( Amlodipine with Atorvastatin)
Arterial Compliance: Structure/Function: Treatment
Selected Combination Antihypertensive Drugs
Hypertension Drug Selection: Summary
New Antihypertensive Drug Classes
Subset Selection of Antihypertensive Therapy
Conclusions 383
References 385
Index 400
... weniger
Autoren-Porträt von Mark Houston
Mark C. Houston, MD, MSc, FACP, FAHA, Associate Clinical Professor of Medicine, Vanderbilt University School of Medicine, ASH Specialist in Clinical Hypertension, Director, Hypertension Institute and Vascular Biology, Nashville, Tennessee, Section Chief, Division of Nutrition and Clinical Research, Staff Physician, Vascular Institute, Saint Thomas Hospital, Nashville, Tennessee.
Bibliographische Angaben
- Autor: Mark Houston
- 2009, 1. Auflage, 404 Seiten, Maße: 13,9 x 21,7 cm, Kartoniert (TB), Englisch
- Verlag: Wiley & Sons
- ISBN-10: 1405182504
- ISBN-13: 9781405182508
- Erscheinungsdatum: 20.04.2009
Sprache:
Englisch
Kommentar zu "Handbook of Hypertension"
0 Gebrauchte Artikel zu „Handbook of Hypertension“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Handbook of Hypertension".
Kommentar verfassen